Reginster JY - Search Results

1

Clinical utility of a pharmacostatistical model for ibandronate in postmenopausal osteoporosis.

Reginster JY, Gieschke R. Reginster JY, et al. Curr Drug Metab. 2006 Oct;7(7):827-36. doi: 10.2174/138920006778520624. Curr Drug Metab. 2006. PMID: 17073582

2

Strontium ranelate in osteoporosis.

Reginster JY. Reginster JY. Curr Pharm Des. 2002;8(21):1907-16. doi: 10.2174/1381612023393639. Curr Pharm Des. 2002. PMID: 12171530 Review.

3

Strontium ranelate: a new paradigm in the treatment of osteoporosis.

Reginster JY, Deroisy R, Jupsin I. Reginster JY, et al. Drugs Today (Barc). 2003 Feb;39(2):89-101. doi: 10.1358/dot.2003.39.2.799416. Drugs Today (Barc). 2003. PMID: 12698204 Review.

4

Prevention of postmenopausal osteoporosis with pharmacological therapy: practice and possibilities.

Reginster JY. Reginster JY. J Intern Med. 2004 Jun;255(6):615-28. doi: 10.1111/j.1365-2796.2004.01292.x. J Intern Med. 2004. PMID: 15147525 Free article. Review.

5

Oral and intravenous ibandronate in the management of postmenopausal osteoporosis: a comprehensive review.

Reginster JY. Reginster JY. Curr Pharm Des. 2005;11(28):3711-28. doi: 10.2174/138161205774580750. Curr Pharm Des. 2005. PMID: 16305506 Review.

6

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study.

Reginster JY, Adami S, Lakatos P, Greenwald M, Stepan JJ, Silverman SL, Christiansen C, Rowell L, Mairon N, Bonvoisin B, Drezner MK, Emkey R, Felsenberg D, Cooper C, Delmas PD, Miller PD. Reginster JY, et al. Ann Rheum Dis. 2006 May;65(5):654-61. doi: 10.1136/ard.2005.044958. Epub 2005 Dec 8. Ann Rheum Dis. 2006. PMID: 16339289 Free PMC article. Clinical Trial.

7

Comprehensive therapy in osteoporosis using a single drug: from ADFR to strontium ranelate.

Manette C, Collette J, Sarlet N, Tancredi A, Zegels B, Reginster JY. Manette C, et al. Among authors: reginster jy. Curr Med Chem. 2006;13(13):1585-90. doi: 10.2174/092986706777442057. Curr Med Chem. 2006. PMID: 16787205 Review.

8

Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate.

Bruyère O, Roux C, Badurski J, Isaia G, de Vernejoul MC, Cannata J, Ortolani S, Slosman D, Detilleux J, Reginster JY. Bruyère O, et al. Among authors: reginster jy. Curr Med Res Opin. 2007 Dec;23(12):3041-5. doi: 10.1185/030079907X242818. Curr Med Res Opin. 2007. PMID: 17967221

9

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, Rizzoli R; European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Kanis JA, et al. Among authors: reginster jy. Osteoporos Int. 2008 Apr;19(4):399-428. doi: 10.1007/s00198-008-0560-z. Epub 2008 Feb 12. Osteoporos Int. 2008. PMID: 18266020 Free PMC article. Review.

10

[Non-hormonal treatments of postmenopausal osteoporosis].

Malaise O, Neuprez A, Reginster JY. Malaise O, et al. Among authors: reginster jy. Gynecol Obstet Fertil. 2008 Jul-Aug;36(7-8):815-22. doi: 10.1016/j.gyobfe.2007.05.026. Epub 2008 Jul 23. Gynecol Obstet Fertil. 2008. PMID: 18653373 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

977 results

Search Page